Endologix Inc (ELGX) SEC Filing 8-K Material Event for the period ending Tuesday, March 5, 2019

Endologix Inc

CIK: 1013606 Ticker: ELGX

View differences made from one to another to evaluate Endologix Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Endologix Inc.


Assess how Endologix Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Endologix Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Endologix Inc provided additional information to their SEC Filing as exhibits

Ticker: ELGX
CIK: 1013606
Form Type: 8-K Corporate News
Accession Number: 0001013606-19-000049
Submitted to the SEC: Tue Mar 05 2019 4:44:03 PM EST
Accepted by the SEC: Tue Mar 05 2019
Period: Tuesday, March 5, 2019
Industry: Surgical And Medical Instruments And Apparatus
  1. Bylaw Change
  2. Financial Exhibit
  3. Other Events
  4. Security Holders Change

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: